ICP-B03

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameICP-B03
Drug Alias NameICP-B03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-15 inhibitors
TargetsInterleukin-15
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnoCare Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnoCare Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A